References
- Angermeyer, M. C., Holzinger, A., Carta, M. G., & Schomerus, G. (2011). Biogenetic explanations and public acceptance of mental illness: Systematic review of population studies. British Journal of Psychiatry, 199(5), 367–372. https://doi.org/10.1192/bjp.bp.110.085563
- Association of Obesity Education. (2021, May 27). ASO webinar: Weight stigma: Insights from research, practice and experience. https://aso.org.uk/resource/aso-webinar-weight-stigma-insights-research-practice-and-experience
- Bell, K. (2017). Health and other unassailable values. Routledge.
- Blanchette, S. (2020). Critiquing the DSM-V narrative of “obesity” as “mental illness. In M. A. Friedman, C. Rice, & J. Rinaldi (Eds.), Thickening fat: Fat bodies, intersectionality, and social justice (pp. 79–89). Routledge.
- Bombak, A. E., Adams, L., & Thille, P. (2022). Drivers of medicalization in the Canadian adult obesity clinical practice guidelines. Canadian Journal of Public Health, 113(5), 743–748. https://doi.org/10.17269/s41997-022-00662-4
- Bombak, A., Eckhart, N., Bensley, J., Cameron, E., Markel, L., & Hughes, K. (2019). Bariatric surgery as prophylaxis: An emerging protection discourse. Social Theory & Health, 19(282), 297. https://doi.org/10.1057/s41285-019-00121-0
- Bombak, A. E., Meadows, A., & Billette, J. (2019). Fat acceptance 101: Midwestern American women’s perspective on cultural body acceptance. Health Sociology Review, 28(2), 194–208. https://doi.org/10.1080/14461242.2019.1604150
- Brown, G. (2023, January 25). The problematic arrival of anti-obesity drugs. Wired. https://www.wired.com/story/anti-obesity-drugs/
- Browne, J. L., Ventura, A., Mosely, K., & Speight, J. (2013). ‘I call it the blame and shame disease’: A qualitative study about perceptions of social stigma surrounding type 2 diabetes. British Medical Journal Open, 3(11), e003384. https://doi.org/10.1136/bmjopen-2013-003384
- Chrisler, J. C., & Barney, A. (2016). Sizeism is a health hazard. Fat Studies, 6(1), 1–16. https://doi.org/10.1080/21604851.2016.1213066
- Corrigan, P. (2019). The stigma effect: Unintended consequences of mental health campaigns. Columbia University Press.
- Crawford, R. (1980). Healthism and the medicalization of everyday life. International Journal of Health Services, 10(3), 365–388. https://doi.org/10.2190/3H2H-3XJN-3KAY-G9NY
- Das, S., & Ungoed-Thomas, J. (2023a, March 12). ‘Orchestrated PR campaign’: How skinny jab drug firm sought to shape obesity debate. The Guardian. https://www.theguardian.com/society/2023/mar/12/orchestrated-pr-campaign-how-skinny-jab-drug-firm-sought-to-shape-obesity-debate
- Das, S., & Ungoed-Thomas, J. (2023b, March 12). Revealed: Experts who praised new ‘skinny jab’ received payments from drug maker. The Guardian. https://www.theguardian.com/business/2023/mar/12/revealed-experts-who-praised-new-skinny-jab-received-payments-from-drug-maker?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1678604657
- Eitenne, V. (2023, January 25). Chelsea Handler ‘didn’t know’ she was on Ozempic, says her doctor ‘just hands it out to anybody’. https://people.com/health/chelsea-handler-didnt-know-she-was-on-ozempic/
- European Association for the Study of Obesity. (2022, January 21). PURPOSE: Understanding the nature and prevalence of obesity stigma in employment. https://easo.org/purpose-understanding-the-nature-and-prevalence-of-obesity-stigma-in-employment/
- Fabbri, A., Lai, A., Grundy, Q., & Bero, L. A. (2018). The influence of industry sponsorship on the research agenda: A scoping review. American Journal of Public Health, 108(11), E9–E16. https://doi.org/10.2105/AJPH.2018.304677
- Federal Drug Administration. (2021, June 4). FDA approves new drug treatment for chronic weight management, first since 2014. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
- Fothergill, E., Guo, J., Howard, L., Kerns, J. C., Knuth, N. D., Brychta, R., Chen, K. Y., Skarulis, M. C., Walter, M., Walter, P. J., & Hall, K. D. (2016). Persistent metabolic adaptation 6 years after ?The biggest loser? Competition. Obesity, 24(8), 1599–1821. https://doi.org/10.1002/oby.21538
- Gingras, J., & Stranz, J.-J. (2023). Magical thinking that permits anti-fat experts to fight fat stigma while also fighting fat. In A. Taylor, K. Ioannoni, A. B. Ramanpreet, C. Evans, A. Scriver, & M. A. Friedman (Eds.), Fat studies in Canada: Remapping the field (pp. 101–123). Inanna Publications.
- Grunvald, E., Shah, R., Hernaez, R., Chandar, A. K., Pickett-Blakely, O., Teigen, L. M., Harindhanavudhi, T., Sultan, S., Singh, S., & Davitkov, P. (2022). AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology, 163(5), 1198–1225. https://doi.org/10.1053/j.gastro.2022.08.045
- Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., Lunsford, D., Mendonca, E., Michalsky, M. P., Mirza, N., Ochoa, E. R., Sharifi, M., Staiano, A. E., Weedn, A. E., Flinn, S. K., … Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2). https://doi.org/10.1542/peds.2022-060640
- Hope, K. (2018, September 24). Weight watchers drops ‘weight’ from name. BBC News. https://www.bbc.com/news/business-45625191
- Ingraham, N. (2021). Fat studies and public health. In C. Pausé & S. R. Taylor (Eds.), Routledge international handbook of fat studies (pp. 165–176). Routledge.
- Kolovos, B. (2022, May 31). Shortage of diabetes medication ozempic after TikTiok users promote drug for weight loss. The Guardian. https://www.theguardian.com/australia-news/2022/may/31/shortage-of-diabetes-medication-ozempic-after-tiktok-users-promote-drug-for-weight-loss
- Larkings, J. S., & Brown, P. M. (2018). Do biogenetic causal beliefs reduce mental illness stigma in people with mental illness and in mental health professionals? A systematic review. International Journal of Mental Health Nursing, 27(3), 928–941. https://doi.org/10.1111/inm.12390
- López-Gil, J. F., García-Hermoso, A., Smith, L., Firth, J., Trott, M., Mesas, A. E., Jiménez-López, E., Gutiérrez-Espinoza, H., Tárraga-López, P.J., & Victoria-Montesinos, D. (2023). Global proportion of disordered eating in children and adolescents: A systematic review and meta-analysis. JAMA Pediatrics, 177(4), 363. https://doi.org/10.1001/jamapediatrics.2022.5848
- MacLean, P. S., Bergouignan, A., Cornier, M. A., & Jackman, M. R. (2011). Biology’s response to dieting: The impetus for weight regain. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 301(3), R581–R600. https://doi.org/10.1152/ajpregu.00755.2010
- Mann, T., Tomiyama, A. J., Westling, E., Lew, A. M., Samuels, B., & Chatman, J. (2007). Medicare’s search for effective obesity treatments: Diets are not the answer. American Psychologist, 62(3), 220–233. https://doi.org/10.1037/0003-066X.62.3.220
- Meadows, A., & Daníelsdóttir, S. (2016). What’s in a word? On weight stigma and terminology [Opinion]. Frontiers in Psychology, 7(1527). https://doi.org/10.3389/fpsyg.2016.01527
- Meyersohn, N. (2023, March 7). Weightwatchers jumps into the prescription weight loss drug business. CNN Business. https://edition.cnn.com/2023/03/07/business/weightwatchers-ozempic/index.html
- Nadolsky, S. [ @DrNadolsky]. (2023, January 11). If giving medicine to people with obesity to help them lose weight makes you feel uncomfortable… then you likely have a bias against those with obesity [tweet]. Twitter. https://twitter.com/DrNadolsky/status/1613230391170588672?s=20&t=OqKvvreF7fXdFEVax___Hw
- National Academies of Sciences, Engineering, and Medicine. (2022). Addressing structural racism, bias, and health communication as foundational drivers of obesity: Proceedings of a workshop series. The National Academies Press. https://doi.org/10.17226/26437
- Novo Nordisk. (2022a). Annual report 2022. https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2023/novo-nordisk-annual-report-2022.pdf
- Novo Nordisk. (2022b, November). It's bigger than me. About the movement: This is more than a mission. https://www.itsbiggerthan.com/about-the-movement/
- Novo Nordisk. (2023a). Disease areas: Obesity: Driving change to defeat stigma and make obesity a healthcare priority. https://www.novonordisk.ca/disease-areas/obesity.html
- Novo Nordisk. (2023b, March). Lose weight and keep it off: This is Wegovy. https://www.wegovy.com/
- Novo Nordisk. (2023c, July). When it comes to losing weight we’ve always had the will. We have another way. https://www.saxenda.com/#:~:text=Saxenda%C2%AE%20(liraglutide)%20injection%203,weight%20and%20keep%20the%20weight
- Obesity Action Coalition. (2022, December 8). Obesity action coalition and the whale. https://www.obesityaction.org/the-whale/
- Obesity Action Coalition. (2023a) Corporate support: Chairman’s council. https://www.obesityaction.org/donate/corporate-support/chairmans-council/
- Obesity Action Coalition. (2023b). Purpose: Our beliefs and demands. https://www.obesityaction.org/about/purpose/beliefs-and-demands/
- Obesity Canada. (2018, September 16). Ask the expert issue #1: Dr. Ximena Ramos Salas on weight bias and discrimination. https://obesitycanada.ca/oc-news/ask-an-expert-issue-1-dr-ximena-ramos-salas-on-weight-bias-and-discrimination/
- Ogden, L. G., Stroebele, N., Wyatt, H. R., Catenacci, V. A., Peters, J. C., Stuht, J., Wing, R.R., & Hill, J. O. (2012). Cluster analysis of the National weight control registry to identify distinct subgroups maintaining successful weight loss. Obesity, 20(10), 2039–2047. https://doi.org/10.1038/oby.2012.79
- Patton, I. (2021). Semaglutide approved in Canada: It’s time to change the game. https://obesitycanada.ca/oc-news/semaglutide-approved-in-canada-its-time-to-change-the-game/
- Petersen, A., & Lupton, D. (1996). The new public health: Health and self in the age of risk. Sage Publications.
- Physician’s Committee for Responsible Medicine. (2023, January 19). News Release. https://www.pcrm.org/news/news-releases/cbs-60-minutes-news-segment-was-unlawful-weight-loss-drug-ad-physicians
- Puhl, R. M., Andreyeva, T., & Brownell, K. D. (2008). Perceptions of weight discrimination: Prevalence and comparison to race and gender discrimination in America. International Journal of Obesity, 32(6), 992–1000. https://doi.org/10.1038/ijo.2008.22
- Puhl, R. M., & Heuer, C. A. (2010). Obesity stigma: Important considerations for public health. American Journal of Public Health, 100(6), 1019–1028. https://doi.org/10.2105/AJPH.2009.159491
- Puhl, R. M., Moss-Racusin, C. A., Schwartz, M. B., & Brownell, K. D. (2008, April). Weight stigmatization and bias reduction: Perspectives of overweight and obese adults. Health Education Research, 23(2), 347–358. https://doi.org/10.1093/her/cym052
- Rinaldi, J., Rice, C., Kotow, C., & Lind, E. (2020). Mapping the circulation of fat hatred. Fat Studies, 9(1), 37–50. https://doi.org/10.1080/21604851.2019.1592949
- Saguy, A. C., & Riley, K. W. (2005). Weighing both sides: Morality, mortality, and framing contests over obesity. Journal of Health Politics, Policy and Law, 30(5), 869–921. https://doi.org/10.1215/03616878-30-5-869
- Shu, Y., He, X., Wu, P., Liu, Y., Ding, Y., & Zhang, Q. (2022). Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.996179
- Treat and Reduce Obesity Act of 2021. H.R.1577 – 117th Congress (2021–2022). https://www.congress.gov/bill/117th-congress/house-bill/1577
- Tylka, T. L., Annunziato, R. A., Burgard, D., Daníelsdóttir, S., Shuman, E., Davis, C., & Calogero, R. M. (2014). The weight-inclusive versus weight-normative approach to health: Evaluating the evidence for prioritizing well-being over weight loss. Journal of Obesity, 2014, 983495. https://doi.org/10.1155/2014/983495
- von Liebenstein, S. (2021, May). Introducing fatness and law – Discrimination, disability, intersectionality. Fat Studies, 10(2), 81–100. https://doi.org/10.1080/21604851.2020.1847868
- Walker, L. (2019). ‘There’s no pill to help you deal with the guilt and shame’: Contemporary experiences of HIV in the United Kingdom. Health (United Kingdom), 23(1), 97–113. https://doi.org/10.1177/1363459317739436
- Weeks, C. (2023, January 13). A weight-loss drug everyone wants is exposing myths about obesity. Globe and Mail. https://www.theglobeandmail.com/canada/article-weight-loss-drug-ozempic-wegovy-obesity/
- West, L. (2023, March 10). The whale is not a masterpiece – it’s a joyless, harmful fantasy of fat squalor. The Guardian. https://www.theguardian.com/film/2023/mar/10/lindy-west-on-the-whale?CMP=oth_b-aplnews_d-1
- Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., Kushner, R. F., & Group S. S (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity & Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725
- Williams, S. J., Martin, P., & Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness, 33(5), 710–725. https://doi.org/10.1111/j.1467-9566.2011.01320.x
- World Obesity Federation. (2022). SCOPE. https://www.worldobesity.org/training-and-events/scope